10 companies
RGEN
Repligen Corp.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs.
Massachusetts
$9,932.0 mm
NASDAQ
CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Switzerland
$4,921.6 mm
NASDAQ
HALO
Halozyme Therapeutics Inc.
we are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.
California
$4,509.8 mm
NASDAQ
IOVA
Iovance Biotherapeutics Inc
iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr.
California
$1,985.9 mm
NASDAQ
ADMA
Adma Biologics Inc
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases.
New Jersey
$1,132.1 mm
NASDAQ
MESO
Mesoblast Ltd
mesoblast; (asx: msb; nasdaq:meso) is a world leader in innovative cell-based medicines.
Australia
$386.8 mm
NASDAQ
PHXM
PHAXIAM Therapeutics S.A.
founded in 2004, erytech is a biopharmaceutical company developing innovative therapies to target unmet medical needs, particularly in the fields of cancer and orphan diseases.
France
$285.5 mm
NASDAQ
CGTX
Cognition Therapeutics Inc
cognition therapeutics inc.
Pennsylvania
$73.6 mm
NASDAQ
AIM
AIM ImmunoTech Inc
aim immunotech inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the united states.
Florida
$20.5 mm
NYSEAMERICAN
MBOT
Microbot Medical Inc
microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision.
Massachusetts
$15.6 mm
NASDAQ
- Prev
- 1
- Next